Search Results 1371-1380 of 18856 for Insulin

  1. Lactated ringer's (intravenous route) - Side effects & uses - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  2. A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity - Mayo Clinic

    Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency, etc.) is not ...

  3. Publications - Dane E. Klett, M.D. - Mayo Clinic

    Role of insulin resistance in uric acid nephrolithiasis. World J Nephrol. 2014 Nov 6; 3 (4):237-42. View PubMed; Sood A, Jeong W, Dalela D, Klett DE, Abdollah ...

  4. Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma - Mayo Clinic

    Patients with controlled Type 1 diabetes mellitus who are on an insulin regimen are eligible for the study. Patients with eczema, psoriasis, lichen simplex ...

  5. Atenolol for the Prevention of Osteoporosis (APO) - Mayo Clinic

    - Clinical diagnosis of diabetes mellitus requiring insulin - Clinically significant abnormality in any of the additional screening laboratory studies - A1c ...

  6. Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery - Mayo Clinic

    ... insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency, etc.) is not considered a form of systemic treatment ...

  7. https://www.mayoclinic.org/spanish_patient_consumer_faq.xml

  8. PCSK9 inhibition: A game changer in cholesterol management - Mayo Clinic

    Placebo- as well as ezetimibe-controlled trials in patients with statin intolerance showed no excess in adverse events such as insulin resistance, glucose ...

  9. Comparing ESG to ESG with APC - Mayo Clinic

    Insulin-dependent diabetes (either Type 1 or Type 2) or a significant likelihood of requiring insulin treatment in the following 12 months or a HgbA1C ≥ 9.

  10. Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer - Mayo Clinic

    Patients with controlled type 1 diabetes mellitus on a stable insulin regimen may be eligible;; Patients with eczema, psoriasis, lichen simplex chronicus of ...